Zambon Group S.p.a.

Zambon S.p.a.

Annibale Gazzaniga

Federico Stroppolo

Daniele Bonadeo

Gian F Fornasini

Valter Gianesello

Francesco Tocchini

Francesco Santangelo

Cesare Casagrande

Franco Pellacini

Giorgio Bertolini

Michele Virno

Luigi Vigano'

Vigano Luigi

Luigi Virgano'

Luciano Soldati

Luigi Vigano

Alessandro Saudino

A syrup containing N-acetyl-cysteine, stable for at least two years, having pleasant taste and smell, consists of an aqueous solution of NAC, a sweetening agent and a thickening agent. The solution can also contain a flavoring agent and a preservative. The pH is between 5 and 8.

Syrup containing N-acetyl-cysteine

Pharmaceutical compositions having analgesic activity containing (S)-2-(6-methoxy-2-naphthyl)-propionic acid as active ingredient and arginine, useful for the preparation of pharmaceutical forms for oral route, are described,

Pharmaceutical composition having analgesic activity

A pharmaceutical composition for oral use having analgesic activity containing a mixture of arginine and (S)-Ibuprofen in a molar ratio between 1.1 and 1.9 is described.

Pharmaceutical compositions for the treatment of cataract containing N-acetyl-L-cysteine derivatives of formula ##STR1## (wherein R and R.sub.1 have the meanings reported in the specification) are described.

Pharmaceutical compositions containing N-acetyl-cysteine derivatives

An ophthalmic pharmaceutical composition containing an association of N-acetyl-cysteine and polyvinylalcohol useful for the treatment of keratoconjunctivitis sicca.

Ophthalmic pharmaceutical composition containing N-acetyl-cysteine and

A pharmaceutical composition for oral use containing the salt of S(+)-2-(4-isobutylphenyl)propionic acid with a basic aminoacid selected between L-arginine and L-lysine is described.

Pharmaceutical compositions containing the salts of

A process for the preparation of salts of 2-(4-isobutylphenyl)propionic acid with basic aminoacids, in particular L-arginine and L-lysine, is described.

Process for the preparation of salts of 2-(4-isobutylphenyl)propionic

A pharmaceutical aqueous solution for ophthalmic use comprising a nonsteroidal anti-inflammatory drug, having a carboxylic group, a decongestant drug and a mixture of a polysorbate and a poloxamer.

Pharmaceutical composition for ophthalmic use comprising a nonsteroidal

A transdermal therapeutic system in polymer matrix for the administration of bronchodilator drugs is described, in which the matrix comprises a mixture of medium and high molecular weight polyisobutylene in a ratio comprised between 1 and 2.3.

Transdermal therapeutic system for the administration of drugs having

A pharmaceutical composition for the treatment of glaucomatous optic neuropathy comprising the 4-[2-(methyl-amino)-ethyl]-1,2-phenylene ester of 2-methylpropanoic acid (Ibopamine) or a pharmaceutically acceptable acid addition salt thereof are described.

Growing community of inventors

Rescaldina, Italy

Annibale Gazzaniga